Loading
TB
Tetra Bio-Pharma Inc. Stock: price and insider trades · Canada
Tetra Bio-Pharma Inc.: what insiders have been doing
This page follows insider dealings at Tetra Bio-Pharma Inc. as filed with SEDI. Nothing new has been filed by managers of Tetra Bio-Pharma Inc. in twelve months, the latest record being from 22 December 2021.
Over the whole record (from 2016), the tally stands at 18 purchases and 133 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
197
Thresholds
n/a
Buy Volume
€132,363
18 ops. · all time
Sell Volume
€4M
133 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 22 December 2021
Declarations197 total
350,000 shares@ CA$0.163100.0% of flowCommon SharesTSXSEDI:3854081
50,000 shares@ CA$0.48235.4% of flowCommon SharesTSXSEDI:3736280
17,410 shares@ CA$0.358.9% of flowCommon SharesTSXSEDI:3735457
17,140 shares@ CA$0.358.8% of flowCommon SharesTSXSEDI:3735454
80,000 shares@ CA$0.2124.6% of flowCommon SharesTSXSEDI:3735450
Common SharesTSXSEDI:3735456
263,157 shares@ CA$0.19100.0% of flowCommon Shares deferred share unitTSXSEDI:3705274
Common Shares deferred share unitTSXSEDI:3705272
defered share unitTSXSEDI:3703835
95,000 shares@ CA$0.2150.3% of flowCommon SharesTSXSEDI:3568734
Canonical exit: 27 Sept 2020 (T+90)
20,000 shares@ CA$0.240.6% of flowCommon SharesTSXSEDI:3553032
Canonical exit: 20 Aug 2020 (T+90)
142,000 shares@ CA$0.531.4% of flowCommon SharesTSXSEDI:3498949
Canonical exit: 13 May 2020 (T+90)
84,000 shares@ CA$0.400.6% of flowCommon SharesTSXSEDI:3487839
Common SharesTSXSEDI:3438095
25,000 shares@ CA$0.30100.0% of flowCommon SharesTSXSEDI:3409572
Common SharesTSXSEDI:3409571
22,700 shares@ CA$0.300.2% of flowCommon SharesTSXSEDI:3404778
84,000 shares@ CA$0.300.5% of flowCommon SharesTSXSEDI:3404295
50,000 shares@ CA$0.3022.3% of flowCommon SharesTSXSEDI:3404135
66,800 shares@ CA$0.30100.0% of flowCommon SharesTSXSEDI:3404188
66,800 shares@ CA$0.302.5% of flowCommon SharesTSXSEDI:3404204
100,000 shares@ CA$0.301.0% of flowCommon SharesTSXSEDI:3400899
3,065 shares@ CA$0.620.2% of flowCommon SharesTSXSEDI:3370110
Canonical exit: 15 Aug 2019 (T+90)
496,385 sharesCommon SharesTSXSEDI:3368277
Common SharesTSXSEDI:3368255
25 of 197 declarations
About Tetra Bio-Pharma Inc.
Tetra Bio-Pharma Inc. is a Canadian company focused on the development of cannabis-based pharmaceuticals. It specializes in research and commercialization of treatments for various medical conditions.
